Curable polymer mixture

Composite formulation containing

• i) 0.01 to 10.00 wt % of a mediator additive component (A),
• ii) 5 to 94 wt % of a filler component (B) and
• iii) 5 to 94 wt % of a binder component (C),
• wherein the mediator additive component (A) has a chemical structure containing the structural elements D, P and E shown in general formula (I)
• [D]aP[E]b (I)
• with
• D the same or different and being selected from the group consisting of (D-I), (D-II), (D-III) and (D-IV)
• with R1 the same or different and represented by hydrogen or CH3;
• R2 the same or different and represented by a branched or unbranched C1-C24-alkyl group,
• a the same or different and represented by an integer from 1 to 50,
• E the same or different and represented by hydrogen and/or being selected from the group consisting of (B-I), (B-II), (B-III) and (B-IV)
• with R3 and R4 in each case the same or different and represent hydrogen or a branched or unbranched C1-C12-alkyl group;
• R5 and R6 in each case are the same or different and represent hydrogen or a branched or unbranched C1-C12-alkyl group;
• R7, R8, R9 and R10 in each case are the same or different and represent hydrogen, COOH or a branched or unbranched C1-C12-alkyl group,
• b is the same or different and represents an integer from 1 to 50,
• P is the same or different and is represented by a branched or unbranched organic principal group, which contains at least two non-terminal ether oxygen atoms within the principal group,
• wherein the principal organic group represented by P has additional terminal oxygen atoms, the structural elements D and E are each bound directly to these terminal oxygen atoms, and a maximum of 70 mol % of the total structural elements E in the chemical structure according to the general formula (I) are H-atoms, and
• wherein the binder component (C) contains at least 60 wt % of preproducts (C′) selected from the group consisting of ethylenically unsaturated polymers, (meth)acrylate resins, and ethylenically unsaturated monomers;
• said preproducts (C′) curable by free radical polymerization with free radical initiators and/or free radical cross-linking with cross-linking agents.